Tag: Halioseek

HalioDx closed a Series B round of €18.5 million (US$22.3 million)

| January 17, 2018 | 0 Comments

This funding will accelerate the development of Immunoscore® in selected cancers, and support set up of commercial activities in the US This round was led by PSIM fund managed by Bpifrance in the framework of the program ‘Investing for the Future’ Marseille, France, January 17, 2018 – HalioDx, a diagnostic company expert in the analysis […]

Continue Reading

HalioDx receives CLIA Compliance for Immunoscore® Colon

| June 21, 2017 | 0 Comments

HalioDx receives CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a turnaround time of 10 days Marseille, June 21, 2017 – HalioDx announced today that the company is compliant under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for its Marseille-based full service […]

Continue Reading